Medicare Enrolled
Dr. Amanda Bucheit, MD
Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bucheit from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bucheit?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bucheit
Dr. Amanda Bucheit is a hematology & oncology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bucheit performed 53,104 Medicare services across 2,687 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bucheit received a total of $3,788 from 49 pharmaceutical and/or device companies across 179 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bucheit is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in TX
$3,788 industry payments
Medicare Practice Summary
Medicare Utilization ↗53,104
Medicare services
Top 18% in TX for hematology & oncology
2,687
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,795 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
45,000 | $1 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
940 | $0 | $0 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
854 | $10 | $32 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
842 | $8 | $23 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
688 | $8 | $15 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
482 | $2 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $65 | $263 |
| Anti-nausea injection (ondansetron/Zofran) | 430 | $0 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
296 | $91 | $373 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
288 | $13 | $41 |
| Iron level test | 288 | $6 | $19 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
288 | $9 | $26 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
200 | $22 | $86 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
194 | $100 | $376 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
193 | $19 | $57 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
173 | $132 | $523 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
149 | $6 | $18 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
129 | $7 | $20 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 113 | $20 | $62 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
111 | $6 | $19 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
98 | $11 | $47 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
96 | $9 | $28 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
94 | $49 | $185 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
92 | $22 | $90 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
77 | $50 | $205 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
67 | $12 | $58 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
60 | $15 | $45 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
60 | $43 | $159 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 60 | $341 | $1,311 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
44 | $5 | $14 |
| New patient office visit, complex (60-74 min) | 40 | $148 | $641 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
38 | $60 | $232 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
37 | $10 | $42 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
35 | $2 | $19 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
28 | $18 | $73 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $112 | $484 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
26 | $10 | $31 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
18 | $5 | $16 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
85.9% high complexity
4.2% medium
9.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,788
Total received (2018-2024)
Avg $541/year across 7 years
Top 47% in TX for hematology & oncology
49
Companies
179
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,672 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$116 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,171
2023
$893
2022
$187
2021
$81
2020
$55
2019
$552
2018
$850
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$356
Novartis Pharmaceuticals Corporation
$327
Genentech USA, Inc.
$324
Daiichi Sankyo Inc.
$264
Regeneron Healthcare Solutions, Inc.
$189
AstraZeneca Pharmaceuticals LP
$176
Medtronic, Inc.
$160
Lucid Diagnostics Inc.
$142
PFIZER INC.
$127
Gilead Sciences, Inc.
$122
Tempus AI, Inc
$114
Astellas Pharma US Inc
$113
Janssen Biotech, Inc.
$98
AVEO Pharmaceuticals, Inc.
$83
PharmaEssentia USA Corporation
$74
Genmab U.S., Inc.
$65
SOBI, INC
$63
Exelixis Inc.
$63
Lilly USA, LLC
$61
Merck Sharp & Dohme Corporation
$59
GlaxoSmithKline, LLC.
$54
Seattle Genetics, Inc.
$51
Pharmacyclics LLC, An AbbVie Company
$45
Celgene Corporation
$45
CTI BioPharma Corp.
$41
PUMA BIOTECHNOLOGY, INC.
$40
ADC Therapeutics America, Inc.
$40
AbbVie, Inc.
$39
Kyowa Kirin, Inc.
$35
Incyte Corporation
$34
Bayer HealthCare Pharmaceuticals Inc.
$29
Seagen Inc.
$29
Agios Pharmaceuticals, Inc.
$25
Janssen Pharmaceuticals, Inc
$24
Apellis Pharmaceuticals, Inc.
$22
Mirati Therapeutics, Inc.
$21
GENZYME CORPORATION
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Kite Pharma, Inc.
$20
EMD Serono, Inc.
$20
Karyopharm Therapeutics Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
ARRAY BIOPHARMA INC
$19
Merck Sharp & Dohme LLC
$19
Puma Biotechnology, Inc.
$17
Blueprint Medicines Corporation
$15
Amgen Inc.
$15
SERVIER PHARMACEUTICALS LLC
$15
JAZZ PHARMACEUTICALS INC.
$13
Top 3 companies account for 26.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · AYVAKIT · Avastin · BESREMI · BOSULIF · Bavencio · CABOMETYX · CALQUENCE · CYRAMZA · DARZALEX · DOPTELET · EMPLICITI · ENHERTU · Empaveli · Enhertu · Epkinly · FARESTON · FOTIVDA · FRUZAQLA · Gazyva · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LYNPARZA · MEKINIST · MYLOTARG · NERLYNX · Nerlynx · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · PADCEV · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pomalyst · RYBREVANT · RYDAPT · Rituxan · SARCLISA · SCEMBLIX · SIGNIA · SUTENT · Stivarga · TAGRISSO · TECENTRIQ · TUKYSA · Tibsovo · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $7 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
57
Per 100K population
2.8
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bucheit is a mixed practice specialist, with above-average Medicare volume (top 18% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bucheit experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Bucheit performed 45,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bucheit receive payments from pharmaceutical companies?
Yes. Dr. Bucheit received a total of $3,788 from 49 companies across 179 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bucheit's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Bucheit's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bucheit) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Antonio
Browse hematology & oncology specialists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology